Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial

Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection Versus Insulin Alone in Type 2 Diabetes

(2018) Kieren J Mather et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans?

(2016) S Lemoine et al.   BRITISH JOURNAL OF ANAESTHESIA

Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism

(2016) Corinna Lebherz et al.   Cardiovascular Diabetology

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies

(2016) Joel P. Giblett et al.   Cardiovascular Diabetology

Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling

(2016) Emma Robinson et al.   Cardiovascular Diabetology

Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac ArrestClinical Perspective

(2016) Sebastian Wiberg et al.   CIRCULATION

Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs

(2015) Juan José Alburquerque-Béjar et al.   CARDIOVASCULAR RESEARCH

Early Detection of Asymptomatic Bypass Graft Abnormalities Using a Cardiac Troponin I Ratio Following Coronary Artery Bypass Surgery

(2015) Andrea Perrotti et al.   JOURNAL OF CARDIAC SURGERY

Impact of Acute Hyperglycemia on Myocardial Infarct Size, Area at Risk, and Salvage in Patients With STEMI and the Association With Exenatide Treatment: Results From a Randomized Study

(2014) J. Lonborg et al.   DIABETES

Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2013) Jong Shin Woo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pharmacologic Therapy That Simulates Conditioning for Cardiac Ischemic/Reperfusion Injury

(2013) Vivek Sivaraman et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Exenatide Reduces Final Infarct Size in Patients With ST-Segment–Elevation Myocardial Infarction and Short-Duration of Ischemia

(2012) Jacob Lønborg et al.   Circulation-Cardiovascular Interventions

Management of Hyperglycemia With the Administration of Intravenous Exenatide to Patients in the Cardiac Intensive Care Unit

(2012) Mohammad Abuannadi et al.   Endocrine Practice

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: The EXAMI study

(2012) Flip J.P. Bernink et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes

(2012) M. Gejl et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Preventive Effects of Exenatide on Endothelial Dysfunction Induced by Ischemia-Reperfusion Injury via K ATP Channels

(2011) Sang Jin Ha et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

(2011) Jacob Lønborg et al.   EUROPEAN HEART JOURNAL

Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery

(2011) Michael J. Domanski   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardioprotective Effects of Glucose and Insulin Administration While Maintaining Normoglycemia (GIN Therapy) in Patients Undergoing Coronary Artery Bypass Grafting

(2011) George Carvalho et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of an insulin infusion protocol during and after cardiac surgery

(2010) C. Studer et al.   DIABETES & METABOLISM

Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting

(2009) Jochen D. Muehlschlegel et al.   EUROPEAN HEART JOURNAL

Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury

(2009) Leo Timmers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Intravenous Glucagon-Like Peptide-1 on Glucose Control and Hemodynamics After Coronary Artery Bypass Surgery in Patients With Type 2 Diabetes

(2008) Karsten Müssig et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION